v3.26.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Integer
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Product Information [Line Items]          
Number of operating segments | Integer     1    
Number of reportable segments | Integer     1    
Cash equivalents $ 0   $ 0   $ 0
Accounts receivable 103,167,960   103,167,960   72,191,994
Cash in excess of federally insured limits 2,616,488   $ 2,616,488   1,427,627
Estimated useful life     3 to 10 years    
Goodwill 4,487,637   $ 4,487,637   4,487,637
Change in fair value of contingent consideration     (990,000)    
Contingent consideration liability 0   0   $ 990,000
Actual revenue     20,000,000    
Revenues 28,252,071 $ 19,078,353 56,290,495 $ 37,676,502  
Breakage Revenue [Member]          
Product Information [Line Items]          
Revenues 75,632 54,934 187,678 156,124  
Settlement Revenue [Member]          
Product Information [Line Items]          
Revenues 0 $ 0 0 $ 0  
Gamma Innovation LLC [Member]          
Product Information [Line Items]          
Fair value gain or loss liability     0    
Selling, General And AdministrativeExpense [Member]          
Product Information [Line Items]          
Change in fair value of contingent consideration 990,000   $ 990,000    
Intangible Assets [Member]          
Product Information [Line Items]          
Intangible asset useful life     3 to 30 years    
Contract Assets [Member]          
Product Information [Line Items]          
Intangible asset useful life     three to five years    
Hosting Implementation [Member]          
Product Information [Line Items]          
Intangible asset useful life     three-year    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Pharma Patient Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage     36.00%   31.00%
Reimbursement Receivables [Member]          
Product Information [Line Items]          
Accounts receivable $ 88,779,628   $ 88,779,628   $ 62,366,232